Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.

Antiviral therapy - 1 Dec 2003

Yuen Man-Fung, Wong Danny Ka-Ho, Sablon Erwin, Yuan He-Jun, Sum Siu-Man, Hui Chee-Kin, Chan Annie On-On, Wang Benjamin Chun-Yu, Lai Ching-Lung

Abstract excerpt

To date, there have been no studies examining the role of hepatitis B virus (HBV) genotypes on the response to lamivudine therapy and the development of YMDD mutations. The present study aimed at determining any differences in the antiviral response and risk of YMDD mutations between lamivudine-treated patients with HBV genotype B and genotype C. Eighty-two patients receiving lamivudine were recruited. HBV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Alanine Transaminase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiviral Agents

Share to Drug Resistance, Viral

Share to Gene Products, pol

Share to Hepatitis B

Share to Hepatitis B virus

Share to Lamivudine

Source

Identifiers

PMID: 14760886

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.PMID 14760886Read ↗

[Effects comparison of lamivudine therapy for hepatitis B virus genotypes B and C].Semantic proximity Read ↗

Hepatitis B genotypes in chronic hepatitis B and lamivudine therapy.Semantic proximity Read ↗

Hepatitis B virus genotypes and lamivudine resistance mutations in Jordan.Semantic proximity Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

HBV genotype B/C and response to lamivudine therapy: a systematic review.Semantic proximity Read ↗

Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.Semantic proximity Read ↗

Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.Semantic proximity Read ↗

[Polymerase region mutations and hepatitis B virus genotypes in chronic hepatitis B patients with poor response to lamivudine].Semantic proximity Read ↗

Clinical characteristics and distribution of hepatitis B virus genotypes in Guangxi Zhuang population.Semantic proximity Read ↗

YMDD mutations and genotypes of hepatitis B virus in northern China.Semantic proximity Read ↗

Hepatitis B virus genotypes and response to antiviral therapy.Semantic proximity Read ↗

Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.